Skip to main content

Advertisement

Log in

Megaprosthesis versus Condyle-sparing Intercalary Allograft: Distal Femoral Sarcoma

  • Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Although functionally appealing in preserving the native knee, the condyle-sparing intercalary allograft of the distal femur may be associated with a higher risk of tumor recurrence and endoprosthetic replacement for malignant distal femoral bone tumors. We therefore compared the risk of local tumor recurrence between patients in these two types of reconstruction groups. We retrospectively reviewed 85 patients (mean age, 22 years; range, 4–82 years), 38 (45%) of whom had a condyle-sparing allograft and 47 (55%) of whom had endoprostheses. The minimum followup for both groups was 2 years (mean, 7 years; range, 2–19 years). Local recurrences occurred in 11% (five of 47) of the patients having implants versus 18% (seven of 38) of the patients having allografts. Using time to local recurrence as an end point, the Kaplan-Meier survivorship of the implant group was similar to that of the condyle-sparing allograft group at 2, 5, and 10 years (93% versus 87% at 2 years, 87% versus 81% at 5 years, and 87% versus 81% at 10 years, respectively). The condyle-sparing allograft procedure offers the potential advantage of retaining the native knee in a young patient population while incurring no greater risk of local recurrence as those offered the endoprosthetic procedure.

Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Alman BA, De Bari A, Krajbich JI. Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents. J Bone Joint Surg Am. 1995;77:54–64.

    PubMed  CAS  Google Scholar 

  2. Bickels J, Wittig JC, Kollender Y, Henshaw RM, Kellar-Graney KL, Meller I, Malawer MM. Distal femur resection with endoprosthetic reconstruction: a long-term followup study. Clin Orthop Relat Res. 2002;400:225–235.

    Article  PubMed  Google Scholar 

  3. Bradish CF, Kemp HB, Scales JT, Wilson JN. Distal femoral replacement by custom-made prostheses. Clinical follow-up and survivorship analysis. J Bone Joint Surg Br. 1987;69:276–284.

    PubMed  CAS  Google Scholar 

  4. Brien E, Terek R, Healey J, Lane J. Allograft reconstruction after proximal tibial resection for bone tumors. An analysis of function and outcome comparing allograft and prosthetic reconstructions. Clin Orthop Relat Res. 1994;303:116–127.

    PubMed  Google Scholar 

  5. Dubousset J, Missenard G, Kalifa C. Management of osteogenic sarcoma in children and adolescents. Clin Orthop Relat Res. 1991;270:52–59.

    PubMed  Google Scholar 

  6. Eckardt JJ, Eilber FR, Rosen G, Mirra JM, Dorey FJ, Ward WG, Kabo JM. Endoprosthetic replacement for stage IIB osteosarcoma. Clin Orthop Relat Res. 1991;270:202–213.

    PubMed  Google Scholar 

  7. Finn HA, Simon MA. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Clin Orthop Relat Res. 1991;262:108–118.

    PubMed  Google Scholar 

  8. Ham SJ, Schraffordt Koops H, Veth RP, van Horn JR, Molenaar WM, Hoekstra HJ. Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol. 1998;5:423–436.

    Article  PubMed  CAS  Google Scholar 

  9. Harris IE, Leff AR, Gitelis S, Simon MA. Function after amputation, arthrodesis, or arthroplasty for tumors about the knee. J Bone Joint Surg Am. 1990;72:1477–1485.

    PubMed  CAS  Google Scholar 

  10. Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. J Bone Joint Surg Am. 1999;81:462–468.

    Article  PubMed  CAS  Google Scholar 

  11. Horowitz SM, Glasser DB, Lane JM, Healey JH. Prosthetic and extremity survivorship after limb salvage for sarcoma. How long do the reconstructions last? Clin Orthop Relat Res. 1993;293:280–286.

    PubMed  Google Scholar 

  12. Kawai A, Backus SI, Otis JC, Healey JH. Interrelationships of clinical outcome, length of resection, and energy cost of walking after prosthetic knee replacement following resection of a malignant tumor of the distal aspect of the femur. J Bone Joint Surg Am. 1998;80:822–831.

    PubMed  CAS  Google Scholar 

  13. Kawai A, Healey JH, Boland PJ, Athanasian EA, Jeon DG. A rotating-hinge knee replacement for malignant tumors of the femur and tibia. J Arthroplasty. 1999;14:187–196.

    Article  PubMed  CAS  Google Scholar 

  14. Kawai A, Lin PP, Boland PJ, Athanasian EA, Healey JH. Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol. 1999;70:109–115.

    Article  PubMed  CAS  Google Scholar 

  15. Kawai A, Muschler GF, Lane JM, Otis JC, Healey JH. Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. Medium to long-term results. J Bone Joint Surg Am. 1998;80:636–647.

    Article  PubMed  CAS  Google Scholar 

  16. Krepler P, Dominkus M, Toma CD, Kotz R. Endoprosthesis management of the extremities of children after resection of primary malignant bone tumors [in German]. Orthopade. 2003;32:1013–1019.

    Article  PubMed  CAS  Google Scholar 

  17. Liptak J, Dernell W, Ehrhart N, Lafferty M, Monteith G, Withrow S. Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Vet Surg. 2006;35:518–533.

    Article  PubMed  Google Scholar 

  18. Lucas D, Kshirsagar M, Biermann J, Hamre M, Thomas D, Schuetze S, Baker L. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist. 2008;13:451–458.

    Article  PubMed  Google Scholar 

  19. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am. 1995;77:1154–1165.

    PubMed  CAS  Google Scholar 

  20. Mankin HJ. The changes in major limb reconstruction as a result of the development of allografts. Chir Organi Mov. 2003;88:101–113.

    PubMed  Google Scholar 

  21. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res. 1996;324:86–97.

    Article  PubMed  Google Scholar 

  22. Morgan HD, Cizik AM, Leopold SS, Hawkins DS, Conrad EU 3rd. Survival of tumor megaprostheses replacements about the knee. Clin Orthop Relat Res. 2006;450:39–45.

    Article  PubMed  Google Scholar 

  23. Muscolo DL, Ayerza MA, Aponte-Tinao LA, Ranalletta M. Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee. J Bone Joint Surg Am. 2004;86:2686–2693.

    PubMed  Google Scholar 

  24. Ortiz-Cruz E, Gebhardt MC, Jennings LC, Springfield DS, Mankin HJ. The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am. 1997;79:97–106.

    PubMed  CAS  Google Scholar 

  25. Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van Horn JR. Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol. 2000;73:198–205.

    Article  PubMed  CAS  Google Scholar 

  26. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994;76:649–656.

    PubMed  CAS  Google Scholar 

  27. Safran MR, Kody MH, Namba RS, Larson KR, Kabo JM, Dorey FJ, Eilber FR, Eckardt JJ. 151 endoprosthetic reconstructions for patients with primary tumors involving bone. Contemp Orthop. 1994;29:15–25.

    PubMed  CAS  Google Scholar 

  28. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am. 1986;68:1331–1337.

    PubMed  CAS  Google Scholar 

  29. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. 1986. J Bone Joint Surg Am. 2005;87:2822.

    Article  Google Scholar 

  30. Tunn PU, Schmidt-Peter P, Pomraenke D, Hohenberger P. Osteosarcoma in children: long-term functional analysis. Clin Orthop Relat Res. 2004;421:212–217.

    Article  PubMed  Google Scholar 

  31. Weiner SD, Scarborough M, Vander Griend RA. Resection arthrodesis of the knee with an intercalary allograft. J Bone Joint Surg Am. 1996;78:185–192.

    PubMed  CAS  Google Scholar 

  32. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, Malawer MM. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65:1123–1132.

    PubMed  Google Scholar 

  33. Zeegen EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004;420:239–250.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Thomas Scharschmidt, MD, and Jedediah White for their assistance in preparing the manuscript for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amy M. Cizik MPH.

Additional information

One of the authors (EUC) has received funding from Stryker Orthopaedics (Mahwah, NJ).

Each author certifies that his or her institution has approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.

This work was performed at the University of Washington Medical Center, Seattle, WA.

About this article

Cite this article

Zimel, M.N., Cizik, A.M., Rapp, T.B. et al. Megaprosthesis versus Condyle-sparing Intercalary Allograft: Distal Femoral Sarcoma. Clin Orthop Relat Res 467, 2813–2824 (2009). https://doi.org/10.1007/s11999-009-1024-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-009-1024-2

Keywords

Navigation